Clinical trial

Dolutegravir Impact on Residual Replication

NCT02500446

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-28

PhasePHASE4

Study timeline

Study start (actual)2015-09-28Date precision: day

Registry last updated2017-11-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

dolutegravirDRUG

PlaceboOTHER

Sponsors & collaborators

University of Melbournelead sponsor

The Alfredcollaborator

ViiV Healthcarecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02500446 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.